雅化集團(002497.SZ):擬終止投資加拿大超鋰項目
格隆匯10月12日丨雅化集團(002497.SZ)公佈,公司於2022年10月11日召開第五屆董事會第十八次會議,會議審議通過了《關於終止對外投資事項的議案》,同意公司全資子公司雅化國際投資發展有限公司(簡稱“雅化國際”)終止與加拿大超鋰公司(英文名:Ultra Lithium Inc.,簡稱“超鋰公司”)的股權認購及礦業權投資事項。
公司根據對當前國際環境的判斷,預計可能會對礦山開發帶來較大影響,導致礦山開發的週期較長,公司擬終止對加拿大超鋰項目的投資。經雙方協商同意,公司於2022年10月11日與超鋰公司簽署了《股權認購協議》的《終止協議》,後續也將簽署協議退出項目公司投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.